Verena M Wagner

Summary

Country: Germany

Publications

  1. ncbi Severe hypoglycaemia, metabolic control and diabetes management in children with type 1 diabetes in the decade after the Diabetes Control and Complications Trial -- a large-scale multicentre study
    Verena M Wagner
    Department of Paediatrics, University Hospital Schleswig Holstein, Campus Lubeck, Ratzeburger Allee 160, 23538 Lubeck, Germany
    Eur J Pediatr 164:73-9. 2005
  2. ncbi Age, metabolic control and type of insulin regime influences health-related quality of life in children and adolescents with type 1 diabetes mellitus
    Verena M Wagner
    Klinik fur Kinder und Jugendmedizin, Universtätsklinikum Schleswig Holstein, Campus Lubeck, Ratzeburger Allee 160, 23538 Lubeck, Germany
    Eur J Pediatr 164:491-6. 2005
  3. ncbi Severe hypoglycemia, metabolic control, and diabetes management in young children with type 1 diabetes using insulin analogs--a follow-up report of a large multicenter database
    Verena M Wagner
    Department of Pediatrics, University Clinic Schleswig-Holstein, , , Germany
    Eur J Pediatr 167:241-2. 2008
  4. ncbi Transition from insulin to sulfonylurea in a child with diabetes due to a mutation in KCNJ11 encoding Kir6.2--initial and long-term response to sulfonylurea therapy
    Verena M Wagner
    Department of Pediatrics, Division of Pediatric Endocrinology and Diabetology, University of Lubeck, Lubeck, Germany
    Eur J Pediatr 168:359-61. 2009

Detail Information

Publications4

  1. ncbi Severe hypoglycaemia, metabolic control and diabetes management in children with type 1 diabetes in the decade after the Diabetes Control and Complications Trial -- a large-scale multicentre study
    Verena M Wagner
    Department of Paediatrics, University Hospital Schleswig Holstein, Campus Lubeck, Ratzeburger Allee 160, 23538 Lubeck, Germany
    Eur J Pediatr 164:73-9. 2005
    ..The therapeutic goal of carefully regulating metabolic control without developing hypoglycaemia has still not been achieved. Further advances in diabetic treatment may result from giving more attention to hypoglycaemia in young children...
  2. ncbi Age, metabolic control and type of insulin regime influences health-related quality of life in children and adolescents with type 1 diabetes mellitus
    Verena M Wagner
    Klinik fur Kinder und Jugendmedizin, Universtätsklinikum Schleswig Holstein, Campus Lubeck, Ratzeburger Allee 160, 23538 Lubeck, Germany
    Eur J Pediatr 164:491-6. 2005
    ..Dimensions of health-related quality of life appear to play different roles at different ages, emphasising the importance of the multidimensional health-related quality of life concept and the value of age-appropriate self-reports...
  3. ncbi Severe hypoglycemia, metabolic control, and diabetes management in young children with type 1 diabetes using insulin analogs--a follow-up report of a large multicenter database
    Verena M Wagner
    Department of Pediatrics, University Clinic Schleswig-Holstein, , , Germany
    Eur J Pediatr 167:241-2. 2008
  4. ncbi Transition from insulin to sulfonylurea in a child with diabetes due to a mutation in KCNJ11 encoding Kir6.2--initial and long-term response to sulfonylurea therapy
    Verena M Wagner
    Department of Pediatrics, Division of Pediatric Endocrinology and Diabetology, University of Lubeck, Lubeck, Germany
    Eur J Pediatr 168:359-61. 2009
    ..2 are the most frequent cause of diabetes in infancy. Sulfonylurea (SU) treatment restores insulin secretion in patients with KCNJ11 mutations...